https://www.selleckchem.com/pr....oducts/pexidartinib-
01. In stepwise regression, age (P=.045), serum ApoA-II (P=.022), and albumin quotient (P.001) were associated with CSF-NfL; albumin quotient (P=.002) and ApoA-II (P=.001) were associated with sNfL. Path analysis identified parallel pathways from ApoA-II (P=.009) and albumin quotient (P.001) to the sNfL outcome that were mediated by CSF-NfL (P.001). The associations of CSF-NfL with ApoA-I (P=.014) and ApoA-II (P=.015) and sNfL with ApoA-II (P.001) remained significant after adjusting for number of contrast